Point of Care Nano-Technology, Inc. (PCNT)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 124.64 Thousand USD | -3.81% |
| 2022 | 129.58 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2015 | 4045.00 USD | -97.72% |
| 2014 | 177.18 Thousand USD | 141644.8% |
| 2013 | 125.00 USD | -71.2% |
| 2012 | 434.00 USD | -92.71% |
| 2011 | 5956.00 USD | -98.8% |
| 2010 | 495.53 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 123.54 Thousand USD | -5.63% |
| 2023 Q4 | 124.64 Thousand USD | 0.89% |
| 2023 Q3 | 123.54 Thousand USD | -5.63% |
| 2023 Q2 | 130.91 Thousand USD | 5.97% |
| 2023 FY | 124.64 Thousand USD | -3.81% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | 130.91 Thousand USD | 30.79% |
| 2022 Q3 | 100.1 Thousand USD | 0.0% |
| 2022 FY | 129.58 Thousand USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2015 Q4 | 4045.00 USD | 41.24% |
| 2015 Q3 | 2864.00 USD | 10507.41% |
| 2015 Q2 | 27.00 USD | -99.8% |
| 2015 Q1 | 13.54 Thousand USD | -92.36% |
| 2015 FY | 4045.00 USD | -97.72% |
| 2014 FY | 177.18 Thousand USD | 141644.8% |
| 2014 Q3 | 5079.00 USD | -79.08% |
| 2014 Q2 | 24.28 Thousand USD | 19482.26% |
| 2014 Q1 | 124.00 USD | -0.8% |
| 2014 Q4 | 177.18 Thousand USD | 3388.5% |
| 2013 Q4 | 125.00 USD | 0.0% |
| 2013 FY | 125.00 USD | -71.2% |
| 2013 Q3 | 125.00 USD | 0.81% |
| 2013 Q2 | 124.00 USD | -49.39% |
| 2013 Q1 | 245.00 USD | -43.55% |
| 2012 Q1 | 674.00 USD | -88.68% |
| 2012 Q2 | 682.00 USD | 1.19% |
| 2012 Q3 | 1057.00 USD | 54.99% |
| 2012 Q4 | 434.00 USD | -58.94% |
| 2012 FY | 434.00 USD | -92.71% |
| 2011 Q4 | 5956.00 USD | -78.46% |
| 2011 FY | 5956.00 USD | -98.8% |
| 2011 Q3 | 27.65 Thousand USD | 0.0% |
| 2010 FY | 495.53 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| America Great Health | 299.12 Thousand USD | 58.331% |
| Ampio Pharmaceuticals, Inc. | 5.73 Million USD | 97.827% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | 99.152% |
| Biora Therapeutics, Inc. | 31.21 Million USD | 99.601% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | 96.129% |
| Better Therapeutics, Inc. | 22.94 Million USD | 99.457% |
| Calithera Biosciences, Inc. | 28.67 Million USD | 99.565% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | 96.656% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | 99.393% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | 99.41% |
| Evelo Biosciences, Inc. | 64.44 Million USD | 99.807% |
| Evolutionary Genomics, Inc. | 2.35 Million USD | 94.704% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | 99.824% |
| Galera Therapeutics, Inc. | 26.14 Million USD | 99.523% |
| Innovation1 Biotech Inc. | 75.99 Thousand USD | -64.019% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | 98.976% |
| Molecular Templates, Inc. | 35.38 Million USD | 99.648% |
| Navidea Biopharmaceuticals, Inc. | 4.37 Million USD | 97.149% |
| NexImmune, Inc. | 8.59 Million USD | 98.55% |
| Orgenesis Inc. | 14.55 Million USD | 99.143% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | 98.944% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | 97.806% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | 68.225% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | 99.974% |
| Statera Biopharma, Inc. | 21.16 Million USD | 99.411% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | 98.767% |
| Trevena, Inc. | 40.6 Million USD | 99.693% |
| Vaxxinity, Inc. | 44.35 Million USD | 99.719% |
| Vaccinex, Inc. | 3.63 Million USD | 96.567% |
| Vicapsys Life Sciences, Inc. | 39.65 Thousand USD | -214.311% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | 99.78% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | 77.571% |